4.1. Therapeutic indications

For the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices.

4.2. Posology and method of administration

By topical application to the oral mucosa.

Adults and children over the age of 16: Using a clean finger massage approximately half an inch of the gel onto the sore area, not more than once every 3hours.

There is no indication that dosage need be modified in the elderly.

Denture irritation: Apply and leave at least 30 minutes before reinsertion of the dentures. Do not apply this product directly to the dentures.

4.3. Contraindications

Not to be used in children and adolescents under the age of 16. This is because there is a possible association between salicylates and Reye's syndrome when given to children. Reye's syndrome is a very rare disease which affects the brain and liver and can be fatal.

Not to be used in patients suffering from active peptic ulceration.

Not to be used in patients with hypersensitivity to salicylates, Acetylsalicylic Acid (Aspirin) or other NSAIDs, or to any of the excipients.

Salicylates and Acetylsalicylic acid: doses > 100 mg/day during the third trimester of pregnancy

4.4. Special warnings and precautions for use

Label warnings: Do not exceed the stated dose. Consult your doctor or dentist before use if you are in the first or second trimester of pregnancy or when symptoms persist for more than seven days. Keep out of the reach of children.

This medicinal product contains 46.83 mg of ethanol (alcohol) in each dose The amount in each dose of this medicine is equivalent to less than 2 ml beer or 1 ml of wine.

The small amount of alcohol in this medicine will not have any noticeable effects.

It may cause burning sensation on damaged skin.

This medicine contains less than 1 mmol sodium (23 mg) in each dose, that is to say essentially 'sodium-free'.

This product contains salicylate and should not be used with Acetylsalicylic Acid (Aspirin) or other salicylates except under the direction of a doctor.

4.5. Interaction with other medicinal products and other forms of interaction

Salicylates may enhance the effect of anticoagulants and inhibit the action of uricosurics.

4.6. Fertility, pregnancy and lactation

Pregnancy:

Salicylates and Acetylsalicylic acid: low doses (up to 100 mg/day):

Clinical studies indicate that doses up to 100 mg/day for restricted obstetrical use, which require specialised monitoring, appear safe.

Breast feeding:

Low quantities of salicylates and of their metabolites are excreted into the breast milk. Since adverse effects for the infant have not been reported up to now, short-term use of the recommended dose does not require suspending breastfeeding.

Fertility:

There is no information on the effects of topical oral choline salicylate and fertility.

4.7. Effects on ability to drive and use machines

None known

4.8. Undesirable effects

The list of the following adverse effects relates to those experienced with topical oral salicylates at OTC doses, in short-term use. In the treatment of chronic conditions, under long-term treatment, additional adverse effects may occur. Adverse events which have been associated with salicylates are given below, listed by system organ class and frequency. Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 and <1/10), uncommon (≥ 1/1000 and <1/100), rare (≥ 1/10,000 and <1/1000), very rare (< 1/10,000) and not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are presented in order of decreasing seriousness.

System Organ Class

Frequency

Adverse Event

Respiratory, Thoracic and Mediastinal Disorders

Not known

Bronchospasm, and asthma1.

Immune System Disorders

Not known

Hypersensitivity

1Salicylates may precipitate bronchospasm and induce asthma attacks in susceptible patients.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

4.9. Overdose

Salicylate toxicity can result if the stated dose is exceeded.

Salicylate poisoning is usually associated with plasma concentrations >350 mg/L (2.5 mmol/L). Most adult deaths occur in patients whose concentrations exceed 700 mg/L (5.1 mmol/L). Single doses less than 100 mg/kg are unlikely to cause serious poisoning. Patients should be given supportive therapy or treatment for salicylate poisoning as necessary. This may include treatment like activated charcoal, urinary alkalinisation and in severe cases haemodialysis.